1-3 of 3
Judith Cruz Velazquez
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Molecular Features of Acute Myeloid Leukemia in Hispanics: An Analysis from the Marrow Consortium

Jesus D Gonzalez-Lugo, Yazan F Madanat, Nidia Zapata, Deedra Nicolet, Victoria Klein, Charles Foucar, Krzysztof Mrózek, Nicole Twardowski, Sharlene Dong, Haitham Abdelhakim, Ana Varela Constantino, Judith Cruz Velazquez, Diana Arcos, Angelica Santiago Medina, Jose Ramiro Espinoza Zamora, Alice Mims, Tara L. Lin, Ann-Kathrin Eisfeld, Onyee Chan, Andres Gomez-De Leon
Journal: Blood
Blood (2024) 144 (Supplement 1): 3801.
https://doi.org/10.1182/blood-2024-212140
Published: 2024
Journal Articles

Imatinib (IM) Plus Thalidomide (Thali), A Effective Combination For The Treatment Of Chronic Myeloid Leukemia (CML) Philadelphia ChromosomePositive (Ph +) In IM-Resistant Disease. Report Of 14 New Cases From A Single Center In Mexico

Rafael Hurtado Monroy, MD, Pablo Vargas-Viveros, MD, Eduardo Cervera Ceballos, MD, Judith Cruz Velazquez, Silvia Carrillo Munos, RN
Journal: Blood
Blood (2013) 122 (21): 5172.
https://doi.org/10.1182/blood.V122.21.5172.5172
Published: 2013
Journal Articles

Chronic Myeloid Leukemia Philadelphia Chromosome Positive (CML Ph+) with Imatinib (IM) Intolerance or Resistant Disease. Response to Thalidomide (TALI) Treatment. Preliminary Report of a Serial of Cases with Encouraging Results

Rafael Hurtado, MD, Jose Pablo Vargas Viveros, MD, Carrillo Muñoz Silvia, RN, Judith Cruz-Velazquez, Myrna Candelaria, MD, PhD, Eduardo Cervera, MD
Journal: Blood
Blood (2012) 120 (21): 1689.
https://doi.org/10.1182/blood.V120.21.1689.1689
Published: 2012